TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Consumer spending dips 0.1% in July as auto sales pull back
  2. Young adults drive home rental trend in Western Pennsylvania
  3. S&P races to August milestone
  4. Government approves compromise on Corbett’s alternative Medicaid plan
  5. UPMC to help China build private medical center to boost public care there
  6. Banks Gas Services finds success in jobs outside shale industry
  7. Auto market booming, but longer loan terms cause concern
  8. 2 top technology officers leave UPMC
  9. EDMC reaches debt-restructuring deal with creditors
  10. Twitch.tv online network reveals value of video gaming market
  11. JPMorgan boosts defenses against mounting cyberattacks
Subscribe today! Click here for our subscription offers.